Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000601818 | SCV000720113 | likely benign | not specified | 2017-06-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002054886 | SCV002447953 | likely benign | Tuberous sclerosis 2 | 2025-01-17 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002483082 | SCV002794674 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2021-10-26 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000055313 | SCV004823507 | benign | Tuberous sclerosis syndrome | 2023-11-30 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV002054886 | SCV005406207 | benign | Tuberous sclerosis 2 | 2024-09-05 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Tuberous sclerosis database |
RCV000055313 | SCV000083533 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |